Progress FSHD completes its data collection ahead of hosting and analysis at France Cohortes

25/07/2025
  • Cohortes
  • News

    • Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common genetic myopathies in adults. Its name reflects the muscles it primarily affects: the face (facio-), the shoulders (scapulo-), and the upper arms (humeral).

    Professor Sacconi’s team at Nice University Hospital is currently collecting data from patients with the condition to build a database hosted within the France Cohortes information system. This data collection is expected to be completed by the end of the year, with analyses – including those using artificial intelligence tools – set to begin in 2026.

    In addition, work led by Professor Sacconi’s team, focused on evaluating a new therapy targeting interleukin-6 in type 1 FSHD, has been selected as a finalist for a prestigious U.S. award dedicated to supporting projects that combat the effects of aging: the FSHD bonus of the XPRIZE Healthspan 2025 challenge (click the link for more information about this prize).